Viruses in therapy—royal road or dead end?
- 1 April 2003
- journal article
- review article
- Published by Elsevier in Virus Research
- Vol. 92 (2) , 219-221
- https://doi.org/10.1016/s0168-1702(02)00355-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Human Immunodeficiency Virus Type 1-Mediated Syncytium Formation Is Compatible with Adenovirus Replication and Facilitates Efficient Dispersion of Viral Gene Products andDe Novo-Synthesized Virus ParticlesHuman Gene Therapy, 2001
- Replication-selective virotherapy for cancer: Biological principles, risk management and future directionsNature Medicine, 2001
- Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck CancerJournal of Clinical Oncology, 2001
- Gene therapy: trials and tribulationsNature Reviews Genetics, 2000
- A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the baylor experience)Annals of Surgical Oncology, 2000
- A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancerNature Medicine, 2000
- Gene therapy - promises, problems and prospectsNature, 1997
- An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor CellsScience, 1996